News Focus
News Focus
icon url

linhdtu

07/06/16 8:01 PM

#202420 RE: DewDiligence #202418

How is the validity of the claim for the superiority of tala vs competition ie ruca and niraparib, ie, efficacy due to parp trapping >>> efficacy due to parp inhibiting ?